Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04169711
Title Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arrowhead Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Aurora Colorado 80045 United States Details
Research Site Las Vegas Nevada 89169 United States Details
Research Site Nashville Tennessee 37232 United States Details
Research Site Dallas Texas 75390 United States Details
Research Site Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field